One thing delaying a full court press PR campaign in Martin's mind could be his desire to get more traction first. Get farther down the road on his plan before showing it to the world - get a decent head start if you will. The reason might be to avoid competition too early. Let's face it, this business plan, as well thought out as it is, did not take huge sums to start it rolling. There is no large "barrier to entry" as they say for others to implement the same strategy. That's part of the genius, but also part of the danger. The entry fee (dollars invested up front) for doing what he's doing is not that high. On the reverse end of "barriers to entry" to get started in an industry, for example, is the auto industry, You can't make a single car till the huge, costly assembly plant is completed. Not so for EWSI. Martin has configured a way using his business acumen to piece together a group of interests in a mutually beneficial way, with no huge outlay up front for him. It's taken his brains and insights and hard work to have a terrific 2013, but not big money if you really think about it in the bigger scheme of things. There are plenty of venture capital folks around, not to mention the many of those with a few million, who would back a good business plan. So hence the need to get relatively established, even have people coming to you to get on board based on reputation. You don't want them, ideally, to have any choices in the matter. EWSI needs to be the only such solution around for a while. JMO. Unfortunately, staying under the radar in this sense does mean a longer gestation time and a longer time for us to see returns. But then if up listing and profitability are coming end of 2014 that's not all that long to wait. Go EWSI!!
One thing delaying a full court press PR campaign in
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors
Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...
Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low
Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...
Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline
Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...
Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion
Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...
Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future
Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...
Continue Reading